Testing effectiveness (Phase 2)Study completedNCT00885170
What this trial is testing
Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)
Who this might be right for
Osteoporosis
Merck Sharp & Dohme LLC 246